Abstract:UNC-51-like kinase 1 (ULK1) is well-known to initiate autophagy, and the downregulation of ULK1 has been found in most breast cancer tissues. Thus, the activation of ULK1-modulated autophagy could be a promising strategy for breast cancer therapy. In this study, we found that ULK1 was remarkably downregulated in breast cancer tissue samples by The Cancer Genome Atlas (TCGA) analysis and tissue microarray (TMA) analysis, especially in triple negative breast cancer (TNBC). To design a ULK1 agonist, we integrated in silico screening and chemical synthesis to acquire a series of small molecule candidates. After rounds of kinase and anti-proliferative activity screening, we discovered the small molecule, LYN-1604, to be the best candidate for a ULK1 agonist. Additionally, we identified that three amino acid residues (LYS50, LEU53, and TYR89) were key to the activation site of LYN-1604 and ULK1 by site-directed mutagenesis and biochemical assays. Subsequently, we demonstrated that LYN-1604 could induce cell death, associated with autophagy by the ULK complex (ULK1-mATG13-FIP200-ATG101) in MDA-MB-231 cells. To further explore LYN-1604-induced autophagic mechanisms, we found some potential ULK1 interactors, such as ATF3, RAD21, and caspase3, by performing comparative microarray analysis. Intriguingly, we found that LYN-1604 induced cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis. Moreover, we demonstrated that LYN-1604 has potential for good therapeutic effects on TNBC by targeting ULK1-modulated cell death in vivo; thus making this ULK1 agonist a novel potential small-molecule drug candidate for future TNBC therapy.

CDK1 phosphorylates ULK1-ATG13 complex to regulate mitotic autophagy and Taxol chemosensitivity

ULK1-ATG13 and Their Mitotic Phospho-Regulation by CDK1 Connect Autophagy to Cell Cycle

Phospho-regulation and function of ULK1-ATG13 during the cell cycle

Phosphorylation of ULK1 Affects Autophagosome Fusion and Links Chaperone-Mediated Autophagy to Macroautophagy

AMPK Regulates Autophagy by Phosphorylating BECN1 at Threonine 388.

Ulk1 Can Suppress Or Promote Tumor Growth Under Different Conditions

Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo

UNC51-like kinase 1, autophagic regulator and cancer therapeutic target.

ULK1 Phosphorylates Mad1 to Regulate Spindle Assembly Checkpoint

CK1δ/ε inhibition induces ULK1-mediated autophagy in tumorigenesis

ULK1 Inhibitor Induces Spindle Microtubule Disorganization and Inhibits Phosphorylation of Ser10 of Histone H3

Effect of Molecular Weight and Charge Ratio on the Stability of the Chitosan/dna Complexes

The mechanism of UNC-51-like kinase 1 and the applications of small molecule modulators in cancer treatment

Phosphorylation of ULK1 by AMPK Regulates Translocation of ULK1 to Mitochondria and Mitophagy.

UNC-51-like Kinase 1: from an Autophagic Initiator to Multifunctional Drug Target

The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14

An autophagy-independent role of ULK1/ULK2 in mechanotransduction and breast cancer cell migration

TRIM27 Cooperates with STK38L to Inhibit ULK1-mediated Autophagy and Promote Tumorigenesis.

A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer

Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy

Serine/Threonine Kinase Unc-51-like Kinase-1 (ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins